American Brain Tumor Association
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$9,844,227
Cash & Equivalents
45%
Investments
35%
Receivables (Non-Related)
10%
Other Assets
4%
Property, Plant, & Equipment (net)
3%
Prepaid Expenses
2%
Related-Party Receivables
0%
Inventories
0%
Liabilities in 2024 (Year End)
$1,831,526
Grants Payable
45%
Other Liabilities
34%
Payables & Accruals
13%
Deferred Revenue
8%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Assets
2023
2024
Change
Cash & Equivalents
$5,489,761
$4,470,437
-19%
Receivables (Non-Related)
$1,067,384
$1,024,826
-4%
Related-Party Receivables
$0
$0
-
Inventories
$0
$0
-
Prepaid Expenses
$214,216
$218,182
+2%
Investments
$3,108,929
$3,463,856
+11%
Property, Plant, & Equipment (net)
$315,637
$254,977
-19%
Other Assets
$476,692
$411,949
-14%
Total Assets
$10,672,619
$9,844,227
-8%
Liabilities
2023
2024
Change
Payables & Accruals
$289,580
$231,562
-20%
Grants Payable
$731,500
$825,000
+13%
Deferred Revenue
$68,477
$154,559
+126%
Tax-Exempt Bond Liabilities
$0
$0
-
Custodial & Escrow Liabilities
$0
$0
-
Notes Payable / Debt (Non-Related)
$0
$0
-
Related-Party Payables
$0
$0
-
Other Liabilities
$671,412
$620,405
-8%
Total Liabilities
$1,760,969
$1,831,526
+4%
Net assets
2023
2024
Change
Restricted Net Assets
$1,752,626
$2,299,366
+31%
Unrestricted Net Assets
$7,159,024
$5,713,335
-20%
Net assets
2023
2024
Change
Net assets
+$8,911,650
+$8,012,701
-10%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)